Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants

NCT05166421 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Corona Virus Disease

Interventions

BIOLOGICAL: AZD7442
BIOLOGICAL: AZD8895 (clonal cell line material)
BIOLOGICAL: AZD1061 (clonal cell line material)
BIOLOGICAL: AZD8895 (cell pool material)
BIOLOGICAL: AZD1061 (cell pool material)

Sponsor

AstraZeneca